BMC Palliative Care (Jul 2024)

Sexual health—a topic for cancer patients receiving oncological treatment with palliative intent

  • Claudia Schmalz,
  • Anne S. Oberguggenberger,
  • Eva Nagele,
  • Brigitte Bliem,
  • Anne Lanceley,
  • Andy Nordin,
  • Karin Kuljanic,
  • Pernille T. Jensen,
  • Vesna Bjelic-Radisic,
  • Alexander Fabian,
  • Juan I. Arraras,
  • Chie Wei-Chu,
  • Carien L. Creutzberg,
  • Razvan Galalae,
  • Hilde Toelen,
  • Kristin Zimmermann,
  • Anna Costantini,
  • Thierry Almont,
  • Samantha Serpentini,
  • Ligita Paskeviciute Frøding,
  • Ingvild Vistad,
  • Krzysztof A. Tomaszewski,
  • Elisabeth Inwald,
  • Elfriede Greimel,
  • the EORTC Quality of Life Group

DOI
https://doi.org/10.1186/s12904-024-01513-4
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Objectives Sexuality is an important dimension of health-related quality of life (HRQOL) in cancer patients. Studies evidence that most patients report impairments of their sexual health related to their disease or its treatment. The Quality of Life Group of the European Organization for the Research and Treatment of Cancer (EORTC) developed a patient reported outcome measure assessing multidimensional aspects of sexual health. The validation study for this instrument revealed heterogenous results for patients in palliative oncological treatment. The aim of this secondary analyses is to examine differences in patient related sexual health outcomes between palliative patients with good performance status (GPS) and those with poor performance status (PPS). Methods In this observational cohort study, self-reported sexual health issue scores were compared between the two groups of patients in palliative oncological treatment with GPS vs PPS status. Results Patients with GPS experienced significantly more sexual satisfaction than patients with PPS (p = 0.015). They reported significantly more treatment effects on their sexual activity (p = 0.005) and suffer more from decreased libido (p = 0.008). Patients with PPS reported significantly more fatigue (p = 0.03) and regarded preservation of sexual activity of higher importance than did patients with GPS (p = 0.049). Conclusions Our study demonstrates the importance of sexuality for patients in palliative oncological treatment, especially for those with limited performance status. Considering the patients´ perspective, sexual health reaches beyond physical functioning. Patients in a palliative phase of disease report high levels of psychosexual problems while sexual performance deteriorates. Sexuality is an important aspect of HRQOL for these patients, needs to be addressed by health care providers and sensitively integrated into palliative care plans.

Keywords